REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN)

1,251 filings reported holding REGN - REGENERON PHARMACEUTICALS, INC. - COMMON STOCK as of Q1 2022.
REGENERON PHARMACEUTICALS, INC. - COMMON STOCK (REGN) has 1,082 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC). These institutions hold a total of 92,282,918 shares of 104,986,330 outstanding shares and own 88% of the company stock.
Largest 10 shareholders include FMR LLC (9,983,024 shares), BlackRock Inc. (9,584,950 shares), VANGUARD GROUP INC (8,360,330 shares), Capital World Investors (5,949,834 shares), STATE STREET CORP (5,125,467 shares), JPMORGAN CHASE & CO (4,964,967 shares), WELLINGTON MANAGEMENT GROUP LLP (2,890,203 shares), LOOMIS SAYLES & CO L P (2,548,047 shares), Dodge & Cox (2,237,063 shares), and GEODE CAPITAL MANAGEMENT, LLC (2,092,771 shares).
This table shows the top 1,082 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.